IPHA
Innate Pharma S.A. - American Depositary Shares (IPHA)
$90
About Innate Pharma S.A. - American Depositary Shares (IPHA)
Innate Pharma SA is a global, clinical-stage biotechnology company, which engages in developing immunotherapies for cancer patients. Its product pipeline includes Lacutamab, Monalizumab, Avdoralimab, and IPH62. The company was founded by Hervé Eloi Dominique Brailly, Eric Vivier, Marc Bonneville, Alessandro Moretta, Jean-Jacques Fournié, and François Romagné on September 23, 1999 and is headquartered in Marseille, France.
Details
Daily high
$1.94
Daily low
$1.85
Price at open
$1.92
52 Week High
$2.71
52 Week Low
$1.17
Market cap
212.2M
Dividend yield
-
Volume
91,438
Avg. volume
43,275
P/E ratio
-3.22
Innate Pharma S.A. - American Depositary Shares News
Details
Daily high
$1.94
Daily low
$1.85
Price at open
$1.92
52 Week High
$2.71
52 Week Low
$1.17
Market cap
212.2M
Dividend yield
-
Volume
91,438
Avg. volume
43,275
P/E ratio
-3.22